The human xenobiotic‐metabolizing enzyme arylamine N‐acetyltransferase 1 (NAT1) is irreversibly inhibited by inorganic (Hg2+) and organic mercury (CH3Hg+): Mechanism and kinetics

[1]  J. Dairou,et al.  Human arylamine N-acetyltransferase 1: a drug-metabolizing enzyme and a drug target? , 2010, Current Drug Targets.

[2]  R. Minchin,et al.  Small molecule inhibition of arylamine N-acetyltransferase Type I inhibits proliferation and invasiveness of MDA-MB-231 breast cancer cells. , 2010, Biochemical and biophysical research communications.

[3]  A. Baeza-Squiban,et al.  Arylamine N-acetyltransferase activity in bronchial epithelial cells and its inhibition by cellular oxidants. , 2009, Toxicology and applied pharmacology.

[4]  Fernando Rodrigues-Lima,et al.  Identification of the Xenobiotic-Metabolizing Enzyme Arylamine N-Acetyltransferase 1 as a New Target of Cisplatin in Breast Cancer Cells: Molecular and Cellular Mechanisms of Inhibition , 2008, Molecular Pharmacology.

[5]  James Robinson,et al.  Arylamine N‐acetyltransferase 1 expression in breast cancer cell lines: A potential marker in estrogen receptor‐positive tumors , 2008, Genes, chromosomes & cancer.

[6]  W. Griffiths,et al.  Deletion of a xenobiotic metabolizing gene in mice affects folate metabolism , 2007, Biochemical and biophysical research communications.

[7]  A. Bozcaarmutlu.  Mechanism of inhibition of purified leaping mullet (liza saliens) NADPH‐cytochrome P450 reductase by toxic metals: Aluminum and thallium , 2007, Journal of biochemical and molecular toxicology.

[8]  Kwangsik Park,et al.  Induction of reactive oxygen species and apoptosis in BEAS-2B cells by mercuric chloride. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[9]  J. Castell,et al.  Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach. , 2005, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[10]  Rudolfs K. Zalups,et al.  Molecular and ionic mimicry and the transport of toxic metals. , 2005, Toxicology and applied pharmacology.

[11]  F. Malecaze,et al.  The Xenobiotic-Metabolizing Enzymes Arylamine N-Acetyltransferases in Human Lens Epithelial Cells: Inactivation by Cellular Oxidants and UVB-Induced Oxidative Stress , 2005, Molecular Pharmacology.

[12]  G. Fakis,et al.  Arylamine N-Acetyltransferases: What We Learn from Genes and Genomes , 2005, Drug metabolism reviews.

[13]  K. Nuttall,et al.  Interpreting mercury in blood and urine of individual patients. , 2004, Annals of clinical and laboratory science.

[14]  A. Harris,et al.  Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro. , 2003, Molecular cancer research : MCR.

[15]  J. Dairou,et al.  Reversible inhibition of the human xenobiotic-metabolizing enzyme arylamine N-acetyltransferase 1 by S-nitrosothiols. , 2003, Biochemical and biophysical research communications.

[16]  R. Cooper,et al.  Skeletal Muscles Express the Xenobiotic-metabolizing Enzyme Arylamine N-acetyltransferase , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  E. Sim,et al.  The COOH Terminus of Arylamine N-Acetyltransferase from Salmonella typhimurium Controls Enzymic Activity* , 2002, Journal of Biological Chemistry.

[18]  M. Fukuhara,et al.  Comparative Study on in vitro Inhibitory Effects of Heavy Metals on Rabbit Drug-Metabolizing Enzymes , 2001 .

[19]  D. Grant,et al.  Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[20]  W. MacNee,et al.  Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. , 2000, Free radical biology & medicine.

[21]  B. Hammock,et al.  Inhibition of soluble and microsomal epoxide hydrolase by zinc and other metals. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  J. Chang,et al.  Inhibition of Na(+)-K(+)-2Cl(-) cotransport by mercury. , 1999, The American journal of physiology.

[23]  R. Minchin.  Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells. , 1995, The Biochemical journal.

[24]  D. Grant,et al.  Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. , 1991, Molecular pharmacology.

[25]  C. Elson,et al.  Influence of mercury (II), cadmium (II), methylmercury, and phenylmercury on the kinetic properties of rat liver glutathione peroxidase. , 1985, Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire.

[26]  S. Cohen,et al.  N-acetylation of drugs: isolation and properties of an N-acetyltransferase from rabbit liver. , 1967, Molecular pharmacology.

[27]  R. Minchin,et al.  Arylamine N-acetyltransferase I. , 2007, The international journal of biochemistry & cell biology.

[28]  M. Doll,et al.  Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[29]  John Doull,et al.  VIRAL DISEASES: A SYMPOSIUM , 1976, The Ulster Medical Journal.